Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a ...

In the latest effort by the Trump administration to reduce costs and increase access to anti-obesity medications like Ozempic ...

CMS launches its Medicare GLP-1 Bridge July 1, giving eligible Medicare Part D beneficiaries access to weight-loss GLP-1s at a $50 monthly copay through December 2027. For health systems and pharmacy ...

The Trump administration decided to put the pilot on hold until at least 2027.

Healthcare providers, suppliers, compliance leaders, and private equity-backed platforms may prepare for increasing operational, ...

Millions of older Americans may have access for the first time to obesity drugs at a low price of $50 a month starting in ...

The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with some downsides takes its place.

The nation's largest physician specialty group is so frustrated by the harmful impacts Medicare Advantage (MA) plans have on ...

The Centers for Medicare and Medicaid Services’ Medicare GLP-1 Bridge program will decrease certain GLP-1 costs, which local ...

Most Medicare and Medicaid beneficiaries leave free benefits unclaimed every year. Here are some you may already qualify for, ...